TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis
Europe - EBR:TESB - BE0003555639 - Common Stock
25.85 EUR
-0.15 (-0.58%)
Overall TESB gets a fundamental rating of 4 out of 10. We evaluated TESB against 71 industry peers in the Chemicals industry. While TESB seems to be doing ok healthwise, there are quite some concerns on its profitability. TESB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year TESB has reported negative net income.
TESB had a positive operating cash flow in the past year.
TESB had positive earnings in each of the past 5 years.
TESB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.96%, TESB is doing worse than 63.38% of the companies in the same industry.
TESB has a Return On Equity of -1.52%. This is in the lower half of the industry: TESB underperforms 61.97% of its industry peers.
The Return On Invested Capital of TESB (2.47%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for TESB is in line with the industry average of 6.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -1.52% | ||
| ROIC | 2.47% |
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
1.3 Margins
TESB's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.61%, TESB is in line with its industry, outperforming 46.48% of the companies in the same industry.
TESB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.33%, TESB is doing worse than 71.83% of the companies in the same industry.
In the last couple of years the Gross Margin of TESB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 19.33% |
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TESB is destroying value.
Compared to 1 year ago, TESB has less shares outstanding
TESB has more shares outstanding than it did 5 years ago.
TESB has a worse debt/assets ratio than last year.
2.2 Solvency
TESB has an Altman-Z score of 2.07. This is not the best score and indicates that TESB is in the grey zone with still only limited risk for bankruptcy at the moment.
TESB's Altman-Z score of 2.07 is in line compared to the rest of the industry. TESB outperforms 45.07% of its industry peers.
TESB has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as TESB would need 2.34 years to pay back of all of its debts.
TESB has a Debt to FCF ratio of 2.34. This is amongst the best in the industry. TESB outperforms 92.96% of its industry peers.
TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
TESB has a better Debt to Equity ratio (0.06) than 88.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 2.34 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.34
WACC7.17%
2.3 Liquidity
TESB has a Current Ratio of 1.94. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TESB (1.94) is better than 64.79% of its industry peers.
A Quick Ratio of 1.18 indicates that TESB should not have too much problems paying its short term obligations.
The Quick ratio of TESB (1.18) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The earnings per share for TESB have decreased strongly by -131.08% in the last year.
The earnings per share for TESB have been decreasing by -20.75% on average. This is quite bad
The Revenue has been growing slightly by 2.05% in the past year.
TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
3.2 Future
Based on estimates for the next years, TESB will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.97% on average per year.
The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
TESB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
TESB is valuated correctly with a Price/Forward Earnings ratio of 14.69.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TESB indicates a somewhat cheap valuation: TESB is cheaper than 69.01% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.30. TESB is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.69 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TESB indicates a rather cheap valuation: TESB is cheaper than 91.55% of the companies listed in the same industry.
84.51% of the companies in the same industry are more expensive than TESB, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.14 | ||
| EV/EBITDA | 5.14 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TESB's earnings are expected to grow with 19.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.83%
EPS Next 3Y19.97%
5. Dividend
5.1 Amount
TESB has a Yearly Dividend Yield of 2.03%. Purely for dividend investing, there may be better candidates out there.
TESB's Dividend Yield is comparable with the industry average which is at 3.05.
Compared to an average S&P500 Dividend Yield of 2.44, TESB has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.03% |
5.2 History
The dividend of TESB is nicely growing with an annual growth rate of 6.16%!
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
TESB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-166.05%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EBR:TESB (10/9/2025, 4:16:48 PM)
25.85
-0.15 (-0.58%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners6.25%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.56B
Analysts74
Price Target27.8 (7.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.03% |
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)22.72%
EPS NY rev (3m)-9.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.47%
Revenue NY rev (3m)-2.21%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 14.69 | ||
| P/S | 0.57 | ||
| P/FCF | 14.14 | ||
| P/OCF | 5.39 | ||
| P/B | 0.87 | ||
| P/tB | 1 | ||
| EV/EBITDA | 5.14 |
EPS(TTM)-0.45
EYN/A
EPS(NY)1.76
Fwd EY6.81%
FCF(TTM)1.83
FCFY7.07%
OCF(TTM)4.8
OCFY18.56%
SpS45.64
BVpS29.62
TBVpS25.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.96% | ||
| ROE | -1.52% | ||
| ROCE | 3.29% | ||
| ROIC | 2.47% | ||
| ROICexc | 2.77% | ||
| ROICexgc | 3.14% | ||
| OM | 2.61% | ||
| PM (TTM) | N/A | ||
| GM | 19.33% | ||
| FCFM | 4.01% |
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexcg growth 3Y-43.17%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 2.34 | ||
| Debt/EBITDA | 0.38 | ||
| Cap/Depr | 80.05% | ||
| Cap/Sales | 6.5% | ||
| Interest Coverage | 7.18 | ||
| Cash Conversion | 97.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.07 |
F-Score6
WACC7.17%
ROIC/WACC0.34
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.08%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year2.34%
Revenue Next 2Y3.91%
Revenue Next 3Y3.83%
Revenue Next 5YN/A
EBIT growth 1Y10.97%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year250.49%
EBIT Next 3Y60.07%
EBIT Next 5YN/A
FCF growth 1Y88.36%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y37.17%
OCF growth 3Y10.33%
OCF growth 5Y8.69%